<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://peptide.global/story/shilpa-cdmo-peptide-investment-raichur</loc><news:news><news:publication><news:name>Peptide Global</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-04T05:29:00.000Z</news:publication_date><news:title>Shilpa CDMO peptide investment puts a first commercial line in Raichur by December</news:title></news:news></url>
  <url><loc>https://peptide.global/story/samsung-biologics-polypeptide-tender-end-result</loc><news:news><news:publication><news:name>Peptide Global</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-03T05:51:00.000Z</news:publication_date><news:title>Samsung Biologics PolyPeptide tender offer ends near 98 percent with settlement waiting on four markets</news:title></news:news></url>
  <url><loc>https://peptide.global/story/korea-obesity-drug-survey-gen-z</loc><news:news><news:publication><news:name>Peptide Global</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-03T05:23:00.000Z</news:publication_date><news:title>Korea obesity drug survey shows Gen Z leading GLP 1 use</news:title></news:news></url>
</urlset>